Cefoxitin And Dextrose Injection, Solution
Product Images NDC 0264-3125

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Cefoxitin And Dextrose (NDC 0264-3125). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by B. Braun Medical Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cefoxitin Sodium (Cefoxitin For Injection And Dextrose Injection In 1)

FDA Label Image

3125-11 50ml 2g Container Label (Cefoxitin For Injection And Dextrose Injection In 10)

3125-11 50ml 2g Container Label (Cefoxitin For Injection And Dextrose Injection In  10)
This is a description of Cefoxitin for Injection and Dextrose Injection contained in a 50mL Duplex container used for intravenous administration. It contains cefoxitin sodium equivalent to 2g, and is recommended to be mixed with a measured volume of the diluent before administration. The instructions for mixing and administration are described in detail in the text. The container is made without natural rubber and is meant for single-dose use. The product is by B Braun Medical.*
FDA Label Image

Drug Chamber Label (Cefoxitin For Injection And Dextrose Injection In 11)

Drug Chamber Label (Cefoxitin For Injection And Dextrose Injection In  11)
This is a label or instruction text for a drug chamber. It advises the user to discard the unit if the foil strip is damaged, and to only peel the foil strip when ready for use. The user is also advised to visually inspect the drug prior to reconstitution, and to refer to the package insert for complete directions for reconstitution and administration.*
FDA Label Image

Dextrous Hydrous (Cefoxitin For Injection And Dextrose Injection In 2)

FDA Label Image

Diagram 1 (Cefoxitin For Injection And Dextrose Injection In 3)

FDA Label Image

Diagram 2 (Cefoxitin For Injection And Dextrose Injection In 4)

FDA Label Image

Diagram 3 (Cefoxitin For Injection And Dextrose Injection In 5)

FDA Label Image

Diagram 4 (Cefoxitin For Injection And Dextrose Injection In 6)

FDA Label Image

Diagram 5 (Cefoxitin For Injection And Dextrose Injection In 7)

FDA Label Image

3123-11 50 mL 1g Container Label (Cefoxitin For Injection And Dextrose Injection In 8)

3123-11 50 mL 1g Container Label (Cefoxitin For Injection And Dextrose Injection In  8)
This is a description of a medication called Cefoxitin for Injection and Dextrose Injection contained within a 50mL DUPLEX® container for intravenous (IV) use. The container is single-dose and sterile/nonpyrogenic, with cefoxitin content equivalent to 1g. It includes instructions for activation by squeezing the chamber below the suction ports. The activated container contains Cefoxitin Sodium USP and Dextrose USP in specified concentrations. The solution is to be stored at room temperature and used within 7-8 hours of preparation. It is free from natural rubber latex, PVC or DEHP. Rx only.*
FDA Label Image

Drug Chamber Label (Cefoxitin For Injection And Dextrose Injection In 9)

Drug Chamber Label (Cefoxitin For Injection And Dextrose Injection In  9)
This is a label instruction for a drug chamber. It asks the user to discard the unit if the foil strip is damaged and to visually inspect the drug prior to using it. The label also suggests that the user must see the package insert for complete directions for reconstitution and administration.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.